Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma

This publication has 30 references indexed in Scilit:

• Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy
  Gynecologic Oncology, 2013
• Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
  Oncogene, 2013
• BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
  Journal of Clinical Oncology, 2012
• Diagnosis of Serous Tubal Intraepithelial Carcinoma Based on Morphologic and Immunohistochemical Features
  American Journal of Surgical Pathology, 2011
• The meaning of p16^ink4aexpression in tumors
  Cell Cycle, 2011
• Serous Tubal Intraepithelial Carcinoma: Diagnostic Reproducibility and its Implications
  International Journal of Gynecological Pathology, 2010
• Mutant p53 Gain-of-Function in Cancer
  Cold Spring Harbor Perspectives in Biology, 2009
• High‐grade ovarian serous carcinoma exhibits significantly higher p16 expression than low‐grade serous carcinoma and serous borderline tumour
  Histopathology, 2007
• Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
  Clinical Medicine & Research, 2007
• Atypical Epithelial Proliferation in Fallopian Tubes in Prophylactic Salpingo-oophorectomy Specimens from BRCA1 and BRCA2 Germline Mutation Carriers
  International Journal of Gynecological Pathology, 2004